Incidence and Prognosis of COVID-19 in Patients With Psoriasis: A Multicenter Prospective Study From the Eastern Black Sea Region of Turkey

This multicenter prospective study investigated the severity of COVID-19 infection in 488 patients with psoriasis in the Eastern Black Sea region of Turkey. The study found that 22.5% of these patients were confirmed to have COVID-19 infection. The hospitalization rates due to COVID-19 infection were similar in patients receiving biological treatment and those receiving non-biological systemic treatment (15.4% and 25.9% respectively, P=0.344). However, hospitalization rates were higher in patients with hypertension, androgenetic alopecia, and those using acitretin (P=0.043, P=0.028, P=0.040). The study concluded that current biologic treatments and non-biologic systemic treatments in patients with psoriasis did not appear to increase the risk of severe COVID-19, except for acitretin.